Symbiomix

Symbiomix Therapeutics is a biopharmaceutical company bringing innovative medicines to market for prevalent gynecological infections than can have serious health consequences. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world’s leading healthcare venture capital firms: OrbiMed, F-Prime Capital Partners, and HBM Partners. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
ADVERTISEMENT

How the Coronavirus Spreads Through the Air: 5 Essential Reads

The Centers for Disease Control and Prevention has given confusing guidance on how COVID-19 spreads through airborne particles; here are the facts.

Science and Technology

Pregnancy During a Pandemic: the Stress of COVID-19 on Pregnant Women and New Mothers Is Showing

The pandemic has dramatically changed the pregnancy experience and the U.S. may have 500,000 fewer births as a result.

Pregnancy & Postpartum